宇山 一朗

Medicine & Life Sciences

1. Gastrectomy 100%
2. Stomach Neoplasms 67%
3. Robotics 47%
4. Lymph Node Excision 32%
5. Stomach 30%
6. Esophagectomy 25%
7. Laparoscopy 21%
8. Orotate Phosphoribosyltransferase 17%
9. Neoplasms 17%
10. Carcinoma 15%
11. Japan 15%
12. Pancreatectomy 14%
13. Dissection 13%
14. Neoplasm Metastasis 13%
15. Gastroenterostomy 12%
16. Liver 12%
17. Lymph Nodes 11%
18. Drug Therapy 11%
19. Pancreaticoduodenectomy 11%
20. Surgeons 10%
21. Recurrence 10%
22. Rectal Neoplasms 10%
23. Hepatic Veins 10%
24. Esophageal Neoplasms 9%
25. Retrospective Studies 8%
26. Minimally Invasive Surgical Procedures 8%
27. Postoperative Complications 8%
28. Cohort Studies 8%
29. Laparotomy 8%
30. Fluorouracil 8%
31. Colorectal Neoplasms 7%
32. Abdominal Wall 7%
33. Capsules 7%
34. Dihydrouracil Dehydrogenase (NADP) 7%
35. Abdomen 6%
36. Chemoradiotherapy 6%
37. Gastrointestinal Stromal Tumors 6%
38. Propensity Score 6%
39. Morbidity 6%
40. Thymidylate Synthase 6%
41. Esophagus 6%
42. Operative Time 6%
43. Cisplatin 6%
44. Esophageal Squamous Cell Carcinoma 5%
45. Hepatectomy 5%
46. Vocal Cord Paralysis 5%
47. Pathologic Constriction 5%
48. Prone Position 5%
49. Pancreatic Fistula 5%
50. Colectomy 5%